Ben Tran is a Medical Oncologist based in Melbourne, working from 305 Grattan Street, VIC 3000. He looks after people who are dealing with cancer, plus some serious non-cancer conditions that can happen alongside treatment. In many cases, care can involve more than just one diagnosis, and Ben helps people make sense of what is going on and what comes next.
Ben’s day-to-day work covers a broad mix of cancers. This includes colorectal cancer, prostate cancer, testicular cancer, bladder cancer (including non-muscle invasive bladder cancer), breast cancer, kidney cancer (renal cell carcinoma), and cancers that can spread, like metastatic brain tumours. He also treats people with cancers of the bile duct (cholangiocarcinoma) and pancreatic cancer, as well as urothelial cancer. At times, treatment plans also need to consider fertility or hormone-related issues, depending on the situation.
Not all problems are cancer. Ben also supports patients with conditions that can show up around illness or during treatment, such as venous thromboembolism (VTE) and deep vein thrombosis (DVT). He may also be involved when someone has febrile neutropenia, agranulocytosis, or other blood and infection concerns that need quick action. Some cases include electrolyte issues like hypophosphataemia, and at times there are situations linked to complex medical histories, like delayed ejaculation or retrograde ejaculation after treatment.
Over time, Ben has built experience in working with people who need careful planning and close follow-up. That often means talking through treatment options in a clear way, explaining side effects, and checking how a patient is coping week to week. He also works with hospital teams when surgery is part of the path, such as after orchiectomy, and when bladder or other procedures are needed as part of the bigger treatment plan.
Education-wise, Ben’s background is in medical oncology, with ongoing learning as cancer care keeps changing. He stays up to date with current cancer research, and in suitable cases he may discuss clinical trial options. This usually comes up when there’s a choice to be made, or when standard options have been limited. The goal stays simple: help patients and families feel informed, supported, and as prepared as possible for what’s ahead.